Worldwide Oligonucleotide API Market Research Report 2021 by Type, Application, Participants and Countries, Forecast Year to 2026
- PRO4358877
- 138 Pages
- April 2021
- Healthcare
Oligonucleotide api market is expected to get to ~ us$ 3 bn in 2020
Antisense oligonucleotide (aso) rehabs to be a vital development vehicle driver
North America holds even more than 2/5th of earnings share as well as is projected to register a cagr of 9% with 2030
Demand for individualized medicines will affect manufacturers approaches
Antisense oligonucleotides api: the torchbearer
Oligonucleotides production has actually been everything about separating api via lyophilization to have a strong product. aqueous solution is formed afterwards on its dissolution.
Nevertheless, in the contemporary context, api manufacturing does not necessarily entail isolating solid api prior to formulation of medicine items. the epoc (European pharma oligonucleotide consortium) has actually worked together with numerous pharma business with the goal of sharing cmc (chemistry, manufacturing, and also control) techniques for allowing harmonization of commercialization and advancement of oligonucleotide.
The antisense course of oligonucleotides has obtained momentum. they got authorized for commercial use in the year 2016. they consist of spinraza, tegsedi, as well as waylivra.
The benefit of these remedy apis (as compared to powder apis) is that they excessively focus on microbial control. moreover, because of elimination of worsening and also dissolution actions, higher efficiency is made certain.
This appears from the truth that antisense oligonucleotides apis account for near 75% of market share and also are expected to witness a cagr of 10% between 2020 and 2030 as per We. the antisense oligonucleotides api targets copd (chronic obstructive pulmonary disease) and bronchial asthma.
Oligonucleotide api makers in development setting
The oligonucleotide api market gamers are into the growth mode to expand the line of therapy to the various other persistent conditions in addition to respiratory system problems. this development has actually been, and is likely to drive the market in the forecast period as well.
For example:
In jan 2020, sta pharmaceutical co., ltd., - a subsidiary to wuxi apptec, introduced opening of its massive oligonucleotide api production facility in changzhou (China) to set up a one-stop system for sustaining oligonucleotide apis production throughout, i.e. from preclinical to business.
In 2019, akcea therapeutics sought the consent to conditionally market waylivra (volanesorsen salt) from the European commissions. waylivra is an adjunct for patients with familial chylomicronaemia syndrome and high threat of pancreatitis.
In apr 2019, cdmo ajinomoto bio-pharma opened a 21,500 sq. ft. plant in Japan for dealing with the growing demand for oligonucleotide.
In jul 2017, nitto denko avecia, a leading producer of oligonucleotide apis, revealed opening of a novel oligonucleotide api production center at milford, ma.
In nov 2017, ge healthcare life scientific researches entered right into a tactical collaboration with guangzhou ribobio co., ltd. at the 5th cnaf (canton nucleic acids online forum), so as to jointly think of Asias biggest oligonucleotide production facility and drug development in China.
Oligonucleotide api market trends
The expanding incidences of cancer cells (based on the international firm for research on cancer, the year 2018 alone saw 17 mn new instances of cancer), the demand for new diagnostics is most likely to witness as well as growth. oligonucleotide apis make means for a completely novel class of nucleic acid probes called aptamers, which are proving to be a lot far better than monoclonal antibodies.
Besides, neurodegenerative problems are requesting for personalized medicines. this pattern is additionally anticipated to influence the oligonucleotide api market in the forecast period.
The senior citizen population is at a greater risk of degenerated nerves. one of the typically taking place neurodegenerative conditions is alzheimers condition. standard medicines have their restrictions on this component. so, substantial research study is being conducted pertaining to use of oligonucleotide apis herein.
For example ; ; lmtx, an anti-tau compound, is reported of having possibility to boost cognitive capacities of the ones influenced with alzheimers. the molecule was administered on mice, in which it generated tau protein that worked as a prevention to tau protein gathering, which inevitably postponed alzheimers diseases development in computer mice. insights like these are bound to compel healthcare experts to attempt oligonucleotide apis for the other chronic conditions also.
Covid-19 effect on oligonucleotide market
The break out of covid-19 has actually briefly delayed the oligonucleotide api market as the manufacturing has actually slowed down owing to partial/total lockdown worldwide. however, the marketplace is anticipated to jump back after subsequent 2 quarters. by then, gamers are most likely to spend a lot more in oligonucleotide apis to seek lasting service to pandemics like these.
Oligonucleotide api market: regional evaluation
As per the us fdas facility for medication examination and also research study, near 28% of making centers concerning apis for the us market are us-based. 13% are China-based et cetera 59% are based in the various other parts of the globe.
Therefore, it can be presumed that the United States and Canada holds the biggest share of oligonucleotide api market. the other qualities consist of strong grip for medication discovery, analysis testing, oncology, protemics, and genomics.
Europe comes in 2nd with extensive study being brought out with regards to use of oligonucleotide apis in dealing with diseases associated with ageing, as Europe is residence to bulk of geriatric population. oriental nations like China and also Japan are the appealing markets owing to massive investments in life science-related programs.
Antisense oligonucleotide apis are sought-after, adhered to by sirna (short conflicting rna). aptamers are expected to catch up in the forecast duration after therapy of neurological disorders being tried by oligonucleotide apis.
Oligonucleotide api: crucial players
The leading 5 players in oligonucleotide api market consist of sarepta therapies, akcea therapeutics, jazz pharmaceuticals, inc., biogen, as well as dynavax innovations. the gamers are focusing on enhancing their local and also worldwide existence in the enterprise options via not natural development methods. at the same time, new item launches have been on the anvil.
For instance ;
Biogen, inc., in may 2019, put forth interim results of stage i/ii research study relative to tofersen for treating als (amyotrophic lateral sclerosis). tofersen is an antisense oligonucleotide (aso).
Dynavax, in the year 2017, launched heplisav-b at the commercial degree. it is a 1-month, 2-dose grown-up liver disease b vaccination.
In 2017, ges dharmacon company partnered with cordenpharma global for creating end-to-end oligonucleotide apis-based medications.
Oligonucleotide api market: the way ahead
The study record on oligonucleotide api by We states that the market would certainly be observing traction in the projection duration (2020-2030) owing to usage of oligonucleotide apis being tried for treating neurological in addition to cardiovascular conditions.
Though covid-19 has negatively affected the production for the time being, the marketplace will certainly get speed in the upcoming months. the market players will have to spend much more on tactical mergings, acquisitions, as well as joint ventures to find up with cutting-edge items to accommodate wider geographies as well as additionally have an one-upmanship over their counterparts.
The study report on oligonucleotide api market gives a referral, summary of market, and also estimate of market growth over the next decade. enhancing study on gene treatment and positive compensation circumstance are in charge of growth of the marketplace at a remarkable price, with the United States and Canada and Europe holding significant share of the global oligonucleotide api market.
Critical mergings and also new item launches by vital market gamers are anticipated to drive the oligonucleotide api market growth. companies with ingenious work capabilities and technological ability will certainly remain in area to sustain a position in oligonucleotide api market.
Oligonucleotide api market: segmentation
Api kind
Antisense oligonucleotides api
Brief conflicting rna (sirna) api
Phosphorodiamidate morpholino oligonucleotides (pmo) api
Mirna api
Aptamers api
Cpg oligonucleotides api
Others (on conjugates (np), shrna, etc.)
Marketing status
Marketed
Scientific tests (scientific phases)
End customer
Contract manufacturing companies (cmos)
Pharmaceutical business
Biopharmaceutical companies
Contract development & production companies (cdmos)
Region
North America
Latin America
Europe
Eastern Asia
South Asia
Oceania
Mea
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Volume Units
1.8 Review Cycle
1.9 Summary and Key Findings of the Research
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach (Involves time, Space, and Persons)
2.3 Data Triangulation
2.4 Assumptions
2.5 Hypothesis of this Research, Clear, specific, and testable statement of this research
2.6 Limitations of Our Study
2.7 Scene Based Modeling
2.8 Covid-19 Impact/Evaluation
3. Market Dynamics
3.1 Driving Factors
3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
3.1.2 Increasing Use of Oligonucleotide API by Different End-User/Applications
3.2 Restraints and Challenges in the Market
3.3 Opportunities
4. Global Oligonucleotide API Market-Segmentation
4.1 By Type
…
4.2 By End-User/Application Industry
…
4.3 By Geography
4.3.1 North America Oligonucleotide API Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.1.1 North America Oligonucleotide API Production from 2014-2020
4.3.1.2 North America Oligonucleotide API Consumption from 2014-2020
4.3.1.3 North America Oligonucleotide API Import and Export from 2014-2020
4.3.1.4 North America Oligonucleotide API Market Value ($) and Growth (%) by Type from 2019-2020
4.3.1.5 North America Oligonucleotide API Market Value ($) and Growth (%) by Application from 2019-2020
4.3.1.6 North America Oligonucleotide API Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.1.7 Top North America Oligonucleotide API Participants Value ($) and Market Share (%) in 2020
4.3.2 Europe Oligonucleotide API Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.2.1 Europe Oligonucleotide API Production from 2014-2020
4.3.2.2 Europe Oligonucleotide API Consumption from 2014-2020
4.3.2.3 Europe Oligonucleotide API Import and Export from 2014-2020
4.3.2.4 Europe Oligonucleotide API Market Value ($) and Growth (%) by Type from 2019-2020
4.3.2.5 Europe Oligonucleotide API Value ($) and Growth (%) by Application from 2019-2020
4.3.2.6 Europe Oligonucleotide API Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.2.7 Top Europe Oligonucleotide API Participants Value ($) and Market Share (%) in 2020
4.3.3 Asia-Pacific Oligonucleotide API Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.3.1 Asia-Pacific Oligonucleotide API Production from 2014-2020
4.3.3.2 Asia-Pacific Oligonucleotide API Consumption from 2014-2020
4.3.3.3 Asia-Pacific Oligonucleotide API Import and Export from 2014-2020
4.3.3.4 Asia-Pacific Oligonucleotide API Value ($) and Growth (%) by Type from 2019-2020
4.3.3.5 Asia-Pacific Oligonucleotide API Value ($) and Growth (%) by Application from 2019-2020
4.3.3.6 Asia-Pacific Oligonucleotide API Value ($) and Growth (%) by Countries from 2019-2020
4.3.3.7 Top Asia-Pacific Oligonucleotide API Participants Value ($) and Market Share (%) in 2020
4.3.4 Latin America Oligonucleotide API Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.4.1 Latin America Oligonucleotide API Production from 2014-2020
4.3.4.2 Latin America Oligonucleotide API Consumption from 2014-2020
4.3.4.3 Latin America Oligonucleotide API Import and Export from 2014-2020
4.3.4.4 Latin America Oligonucleotide API Value ($) and Growth (%) by Type from 2019-2020
4.3.4.5 Latin America Oligonucleotide API Value ($) and Growth (%) by Application from 2019-2020
4.3.4.6 Latin America Oligonucleotide API Value ($) and Growth (%) by Countries from 2019-2020
4.3.4.7 Top Latin America Oligonucleotide API Participants Value ($) and Market Share (%) in 2020
4.3.5 Middle East & Africa Oligonucleotide API Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.5.1 Middle East & Africa Oligonucleotide API Production from 2014-2020
4.3.5.2 Middle East & Africa Oligonucleotide API Consumption from 2014-2020
4.3.5.3 Middle East & Africa Oligonucleotide API Import and Export from 2014-2020
4.3.5.4 Middle East & Africa Oligonucleotide API Value ($) and Growth (%) by Type from 2019-2020
4.3.5.5 Middle East & Africa Oligonucleotide API Value ($) and Growth (%) by Application from 2019-2020
4.3.5.6 Middle East & Africa Oligonucleotide API Value ($) and Growth (%) by Countries from 2019-2020
4.3.5.7 Top Middle East & Africa Oligonucleotide API Participants Value ($) and Market Share (%) in 2020
5. Global Level Competitive Intelligence – Company Profiles
5.1 Company one
5.1.1 Company one Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.1.2 Company one Sales, Growth Rate and Global Market Share from 2014-2020
5.2 Company two
5.2.1 Company two Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.2.2 Company two Sales, Growth Rate and Global Market Share from 2014-2020
5.3 Company three
5.3.1 Company three Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.3.2 Company three Sales, Growth Rate and Global Market Share from 2014-2020
5.4 Company four
5.4.1 Company four Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.4.2 Company four Sales, Growth Rate and Global Market Share from 2014-2020
5.5 Company five
5.5.1 Company five Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.5.2 Company five Sales, Growth Rate and Global Market Share from 2014-2020
5.6 Company six
5.6.1 Company six Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.6.2 Company six Sales, Growth Rate and Global Market Share from 2014-2020
5.7 Company seven
5.7.1 Company seven Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.7.2 Company seven Sales, Growth Rate and Global Market Share from 2014-2020
5.8 Company eight
5.8.1 Company eight Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.8.2 Company eight Sales, Growth Rate and Global Market Share from 2014-2020
5.9 Company nine
5.9.1 Company nine Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.9.2 Company nine Sales, Growth Rate and Global Market Share from 2014-2020
5.10 Company ten
5.10.1 Company ten Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.10.2 Company ten Sales, Growth Rate and Global Market Share from 2014-2020
5.11 Company 11
5.11.1 Company 11 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.11.2 Company 11 Sales, Growth Rate and Global Market Share from 2014-2020
5.12 Company 12
5.12.1 Company 12 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.12.2 Company 12 Sales, Growth Rate and Global Market Share from 2014-2020
5.13 Company 13
5.13.1 Company 13 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.13.2 Company 13 Sales, Growth Rate and Global Market Share from 2014-2020
5.14 Company 14
5.14.1 Company 14 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.14.2 Company 14 Sales, Growth Rate and Global Market Share from 2014-2020
5.15 Company 15
5.15.1 Company 15 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.15.2 Company 15 Sales, Growth Rate and Global Market Share from 2014-2020
...
6. Investment Analysis
6.1 Fundamental Analysis (Porter's Five Forces Analysis)
6.2 Technical Preparation Analysis
6.3 Risk Evaluating Analysis
6.4 Estimated Investment Pay-Back Period
7. Future Forecast of Global Oligonucleotide API Market from 2020-2026
7.1 Future Forecast of Global Oligonucleotide API Market from 2020-2026 Segment by Regions
7.2 Future Forecast of Global Oligonucleotide API Market from 2020-2026 Segment by Type
7.3 Future Forecast of Global Oligonucleotide API Market from 2020-2026 Segment by Application
8 Appendix
8.1 Discussion Guide
8.2 Related Reports
8.3 Author List
1005 Disclaimer
Table Key Data from Secondary Sources
Table Key Data Parameter
Figure Market Size Estimation by End-Use Industry
Figure Market: Data Triangulation
Figure Market Size Estimation: Top-Down Approach
Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)
Table Global Oligonucleotide API Production and Growth Rate Segment by Product Types from 2014-2020
Table Global Oligonucleotide API Value ($) and Growth Rate Segment by Product Types from 2014-2020
Figure Type 1 of Oligonucleotide API
Figure Type 2 of Oligonucleotide API
Figure Type 3 of Oligonucleotide API
Table Global Oligonucleotide API Consumption and Growth Rate Segment by End-User/Application from 2014-2020
Table Global Oligonucleotide API Value ($) and Growth Rate Segment by End-User/Application from 2014-2020
Figure Application 1 of Oligonucleotide API
Figure Application 2 of Oligonucleotide API
Figure Application 3 of Oligonucleotide API
Table Global Oligonucleotide API Production Value ($) by Regions
Table Global Oligonucleotide API Production Value Share by Regions
Table Global Oligonucleotide API Production by Regions
Table Global Oligonucleotide API Production Share by Regions
Table Global Oligonucleotide API Consumption by Regions
Table Global Oligonucleotide API Consumption Share by Regions
Figure North America Oligonucleotide API Production and Growth Rate from 2014-2020
Figure North America Oligonucleotide API Consumption and Growth Rate from 2014-2020
Table North America Oligonucleotide API Import and Export from 2014-2020
Table North America Oligonucleotide API Value ($) and Growth (%) by Type from 2019-2020
Table North America Oligonucleotide API Value ($) and Growth (%) by Application from 2019-2020
Table North America Oligonucleotide API Value ($) and Growth (%) by Countries from 2019-2020
Table Top North America Oligonucleotide API Participants Value ($) and Market Share (%) in 2020
Figure Europe Oligonucleotide API Production and Growth Rate from 2014-2020
Figure Europe Oligonucleotide API Consumption and Growth Rate from 2014-2020
Table Europe Oligonucleotide API Import and Export from 2014-2020
Table Europe Oligonucleotide API Value ($) and Growth (%) by Type from 2019-2020
Table Europe Oligonucleotide API Value ($) and Growth (%) by Application from 2019-2020
Table Europe Oligonucleotide API Market Value ($) and Growth (%) by Countries from 2019-2020
Table Top Europe Oligonucleotide API Participants Value ($) and Market Share (%) in 2020
Figure Asia-Pacific Oligonucleotide API Production and Growth Rate from 2014-2020
Figure Asia-Pacific Oligonucleotide API Consumption and Growth Rate from 2014-2020
Table Asia-Pacific Oligonucleotide API Import and Export from 2014-2020
Table Asia-Pacific Oligonucleotide API Value ($) and Growth (%) by Type from 2019-2020
Table Asia-Pacific Oligonucleotide API Value ($) and Growth (%) by Application from 2019-2020
Table Asia-Pacific Oligonucleotide API Value ($) and Growth (%) by Countries from 2019-2020
Table Top Asia-Pacific Oligonucleotide API Participants Value ($) and Market Share (%) in 2020
Figure Latin America Oligonucleotide API Production and Growth Rate from 2014-2020
Figure Latin America Oligonucleotide API Consumption and Growth Rate from 2014-2020
Table Latin America Oligonucleotide API Import and Export from 2014-2020
Table Latin America Oligonucleotide API Value ($) and Growth (%) by Type from 2019-2020
Table Latin America Oligonucleotide API Value ($) and Growth (%) by Application from 2019-2020
Table Latin America Oligonucleotide API Value ($) and Growth (%) by Countries from 2019-2020
Table Top Latin America Oligonucleotide API Participants Value ($) and Market Share (%) in 2020
Figure Middle East & Africa Oligonucleotide API Production and Growth Rate from 2014-2020
Figure Middle East & Africa Oligonucleotide API Consumption and Growth Rate from 2014-2020
Table Middle East & Africa Oligonucleotide API Import and Export from 2014-2020
Table Middle East & Africa Oligonucleotide API Value ($) and Growth (%) by Type from 2019-2020
Table Middle East & Africa Oligonucleotide API Value ($) and Growth (%) by Application from 2019-2020
Table Middle East & Africa Oligonucleotide API Value ($) and Growth (%) by Countries from 2019-2020
Table Top Middle East & Africa Oligonucleotide API Participants Value ($) and Market Share (%) in 2020
Table Company one Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company one Sales and Growth Rate from 2014-2020
Figure Company one Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company two Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company two Sales and Growth Rate from 2014-2020
Figure Company two Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company three Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company three Sales and Growth Rate from 2014-2020
Figure Company three Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company four Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company four Sales and Growth Rate from 2014-2020
Figure Company four Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company five Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company five Sales and Growth Rate from 2014-2020
Figure Company five Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company six Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company six Sales and Growth Rate from 2014-2020
Figure Company six Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company seven Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company seven Sales and Growth Rate from 2014-2020
Figure Company seven Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company eight Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company eight Sales and Growth Rate from 2014-2020
Figure Company eight Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company nine Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company nine Sales and Growth Rate from 2014-2020
Figure Company nine Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company ten Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company ten Sales and Growth Rate from 2014-2020
Figure Company ten Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 11 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 11 Sales and Growth Rate from 2014-2020
Figure Company 11 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 12 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 12 Sales and Growth Rate from 2014-2020
Figure Company 12 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 13 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 13 Sales and Growth Rate from 2014-2020
Figure Company 13 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 14 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 14 Sales and Growth Rate from 2014-2020
Figure Company 14 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 15 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 15 Sales and Growth Rate from 2014-2020
Figure Company 15 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Global Oligonucleotide API Value ($) and Growth Rate Forecast by Regions (2020-2026)
Table Global Oligonucleotide API Production and Growth Rate Forecast by Regions (2020-2026)
Table Global Oligonucleotide API Consumption and Growth Rate Forecast by Regions (2020-2026)
Table Global Oligonucleotide API Production and Growth Rate Forecast by Types (2020-2026)
Table Global Oligonucleotide API Consumption and Growth Rate Forecast by End-User/Applications (2020-3022)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
